Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Agilent, Definiens, and More


Agilent this week appointed Ron Nersesian president and chief operating officer.

Nersesian had previously been executive vice president and chief operating officer at Agilent, where he was responsible for the company's Chemical Analysis, Life Sciences, Electronic Measurement, and Agilent Order Fulfillment businesses. He will continue to be responsible for these groups, the company said.

Definiens this week appointed Gerald Moller chairman of its supervisory board.

Previously, Moller held a number of leadership positions at Boehringer Mannheim, including president of decentralized diagnostics and president of advanced diagnostics and biochemicals.

Amarantus Biosciences this week appointed Robert Zimmerman its product development advisor.

Zimmerman runs biopharmaceutical product development consulting business Zimmerman Consulting. Previously he was chief operating officer and president at Signature Bioscience as well as vice president of biotechnology researcher at Bayer.

Johns Hopkins University researcher and mass spectrometry pioneer Robert Cotter passed away this week.

Cotter was a professor of pharmacology and molecular sciences and a leader in the development of time-of-flight mass spectrometry technology, particularly for protein and peptide analysis. He received his MS and PhD in physical chemistry from Johns Hopkins and joined the faculty in 1978.

During his career he served as the president of the American Society for Mass Spectrometry as well as director of the Middle Atlantic Mass Spectrometry Laboratory.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.